Patents Assigned to Salo Pharmaceutical Co., Ltd.
  • Patent number: 7223773
    Abstract: The present invention provides a 4-oxoquinolizine antibacterial agent having a 2-pyridone skeleton as a partial structure and also having a strong antibacterial effect on gram-positive bacteria, gram-negative bacteria or anaerobic bacteria. The compound having the following formula (I) or a pharmaceutically acceptable salt thereof: wherein: R1 represents hydrogen atom or a carboxyl-protecting group, R2 represents hydrogen atom, a halogen atom, a lower alkyl group, a lower alkoxyl group or hydroxyl group, R3 represents phenyl group or an aromatic substituent selected from the group consisting of 5-membered and 6-membered heterocyclic groups and R3 has a substituent selected from the group consisting of a hydrogen atom, a lower alkyl group, a lower alkoxyl group, a nitro group, a cyano group, an amino group, an acyl group, a carbamoyl group and a ureido group, and R4 represents a hydrogen atom or a halogen atom.
    Type: Grant
    Filed: March 26, 2004
    Date of Patent: May 29, 2007
    Assignee: Salo Pharmaceutical Co., Ltd.
    Inventors: Ryoichi Fukumoto, Yoshimi Niwano, Hiroyuki Kusakabe, Chong Chu, Hiroaki Kimura, Koh Nagasawa, Satoshi Yanagihara, Chisato Hirosawa, Seiji Ishiduka